Back to search

University of Leeds

Interferon-dependant chemoresistance in breast cancer

Abstract

dc:description.abstract

Chemoresistance is a major obstacle in the treatment of primary and metastatic breast cancer (BC). Identifying chemoresistance mechanisms utilised by cancer cells is therefore an important step towards sensitising tumours to chemotherapy and improving treatment outcomes. The Hughes group has recently identified an IFN-dependent resistance pathway in claudin-low triple negative breast cancer (TNBC). In this thesis, the relevance of IFN-dependent epirubicin resistance was assessed in multiple BC cell lines representing claudin-low TNBC (MDA-MB-231), HER2-enriched (AU565), luminal A (MCF-7) and luminal B (BT-474) BC through MTT and colony forming assays. The ability of IFN to induce docetaxel resistance was also assessed. The effect of IFN on epirubicin-induced DNA double stranded break formation was investigated in MDA-MB-231 through a γ-H2Ax immunofluorescence assay. In addition, the clinical relevance of IFN signalling was assessed in a cohort of 27 metastatic TNBC patients through immunohistochemical evaluation of IFNβ1 and MX1 expression in cancer and stromal cells. Viability assays showed IFNα1 induced a dose-dependent epirubicin resistance in MDA-MB231 but did not induce resistance in AU565, MCF-7 or BT-474 cells. Moreover, IFN did not induce resistance to docetaxel in any cell lines tested. In MDA-MB-231 cells, the addition of IFNα1 significantly reduced epirubicin-induced expression of γ-H2Ax. Analysis of the cohort of metastatic TNBC patients showed a significant correlation between IFNβ1 expression in lymphocytes and MX1 expression in cancer cells, however this was not associated with survival. In conclusion, this thesis has shown IFN-dependent resistance to be subtype and chemotherapy dependant in BC. Moreover, this thesis has identified paracrine IFN signalling within the TNBC metastatic tumour microenvironment. Further study into the inhibition of this pathway may lead to chemosensitising treatments and improved patient outcomes in claudin-low TNBC. Additionally, investigation of the clinical relevance of this pathway in metastatic BC should be performed using a larger cohort.

Degree

thesis:*
Name dc:type.qualificationname
M.Sc by research
Level dc:type.qualificationlevel
masters
Grantor dc:publisher.institution
University of Leeds
Year dc:date.issued
2022

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • McLoughlin, Louis Francis Vaughan
Advisors dc:contributor.advisor
  • Hughes, Thomas
  • Volpato, Milene
ORCID person:identifier.orcid

Rights

Language dc:language.dcterms_iso639_2
eng

Chain of custody

source
Harvested from
White Rose University Consortium
Base URL
etheses.whiterose.ac.uk/cgi/oai2
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
related terms
citation

McLoughlin, Louis Francis Vaughan. Interferon-dependant chemoresistance in breast cancer. masters thesis, University of Leeds, 2022.